SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced today that it plans to report third quarter 2009 financial results on Thursday, November 5, 2009, following the close of market. Ligand’s President and CEO, John L. Higgins, Vice President of Finance and CFO, John Sharp and Vice President of Discovery Research, Dr. Martin Meglasson will host the conference call.
